Enanta Pharmaceuticals
ENTA
#8491
Rank
NZ$0.51 B
Marketcap
NZ$17.54
Share price
-9.61%
Change (1 day)
-22.34%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -NZ$87.33 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are NZ$65.25 Million. In 2025 the company made an earning of -NZ$0.12 Billion, an increase over its 2024 earnings that were of -NZ$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$87.33 Million-24.91%
2025 -NZ$0.12 Billion-34.07%
2024 -NZ$0.18 Billion-23.87%
2023 -NZ$0.24 Billion4.39%
2022 -NZ$0.23 Billion-4.4%
2021 -NZ$0.24 Billion91.12%
2020 -NZ$0.13 Billion-407.13%
2019 NZ$39.55 M-78.63%
2018 NZ$0.18 B117.97%
2017 NZ$84.93 M-574.65%
2016 -NZ$17.9 Million-110.83%
2015 NZ$0.16 B-4.5%
2014 NZ$0.17 B-638.53%
2013 -NZ$32.14 Million-137.98%
2012 NZ$84.6 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.04 B-37,381.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$22.99 B-25,277.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$23.30 B-25,618.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.29 B-9,183.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.22 B-13,488.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$20.60 B-22,666.96%๐Ÿ‡บ๐Ÿ‡ธ USA